Richard W. Fuller

7.1k total citations
101 papers, 5.4k citations indexed

About

Richard W. Fuller is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Richard W. Fuller has authored 101 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Physiology, 36 papers in Pulmonary and Respiratory Medicine and 20 papers in Molecular Biology. Recurrent topics in Richard W. Fuller's work include Asthma and respiratory diseases (40 papers), Respiratory and Cough-Related Research (25 papers) and Inhalation and Respiratory Drug Delivery (11 papers). Richard W. Fuller is often cited by papers focused on Asthma and respiratory diseases (40 papers), Respiratory and Cough-Related Research (25 papers) and Inhalation and Respiratory Drug Delivery (11 papers). Richard W. Fuller collaborates with scholars based in United Kingdom, United States and Norway. Richard W. Fuller's co-authors include Michael R. Boyd, John H. Cardellina, C. T. Dollery, Kevin M. O’Shaughnessy, Nozhat Choudry, Joe Collier, Peter J. Barnes, Ian Taylor, Kirk R. Gustafson and Tawnya C. McKee and has published in prestigious journals such as Science, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Richard W. Fuller

100 papers receiving 5.1k citations

Peers

Countries citing papers authored by Richard W. Fuller

Since Specialization

Citations

This map shows the geographic impact of Richard W. Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard W. Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard W. Fuller more than expected).

Fields of papers citing papers by Richard W. Fuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard W. Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard W. Fuller. The network helps show where Richard W. Fuller may publish in the future.

Co-authorship network of co-authors of Richard W. Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of Richard W. Fuller. A scholar is included among the top collaborators of Richard W. Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard W. Fuller. Richard W. Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bradykinin-induced Bronchoconstriction in Humans 2015 ·American Review of Respiratory Disease ·Richard W. Fuller, Caroline Dixon, Francis M. Cuss, Peter J. Barnes	3
2	Inhibition of IL-4 and IL-13 with an IL-4 mutein (Aeroderm) protects against flares in atopic eczema 2007 ·Journal of Investigative Dermatology ·Richard Groves, Darren Wilbraham, Richard W. Fuller, Malinda Longphre	8
3	Imaging allergen-invoked airway inflammation in atopic asthma with [18F]-fluorodeoxyglucose and positron emission tomography 1996 ·The Lancet ·Ian Taylor, Michael Hayes, B J O'Connor, H. A. Jones, J. M. B. Hughes, N. B. Pride, (unknown), Kevin M. O’Shaughnessy, C. G. Rhodes, Timothy Peter Jones, Richard W. Fuller	51
4	Capsaicin Cough Sensitivity Decreases with Successful Treatment of Chronic Cough 1994 ·American Journal of Respiratory and Critical Care Medicine ·Finbarr O’Connell, (unknown), N. B. Pride, Richard W. Fuller	187
5	Nonbronchodilator Effects of Inhaled Beta 2 Agonists. Greater Protection Against Adenosine Monophosphate- Than Methacholine-Induced Bronchoconstriction in Asthma 1994 ·American Journal of Respiratory and Critical Care Medicine ·B J O'Connor, Richard W. Fuller, Peter J. Barnes	42
6	Cucurbitacins: Differential Cytotoxicity, Dereplication and First Isolation from Gonystylus keithii 1994 ·Journal of Natural Products ·Richard W. Fuller, John H. Cardellina, Gordon M. Cragg, Michael R. Boyd	33
7	The effect of topical sodium cromoglycate on intranasal histamine challenge in allergic rhinitis 1994 ·Clinical Otolaryngology ·Martin Birchall, (unknown), (unknown), N. B. Pride, Richard W. Fuller	4
8	Controversies in Management: Adverse effects are not proved: FIG 1994 ·BMJ ·Richard W. Fuller	3
9	Comparison of the Effect of Inhaled Selective and Non-selective Adrenergic Agonists on Cardiorespiratory Parameters in Chronic Stable Asthma 1994 ·Pulmonary Pharmacology ·A.J. Williams, (unknown), D.B. Reiff, Erik R. Swenson, Richard W. Fuller, John Hughes	7
10	Inhibitory actions of salmeterol on human airway macrophages and blood monocytes 1994 ·European Journal of Pharmacology ·Amanda J. Baker, James Palmer, Malcolm Johnson, Richard W. Fuller	19
11	Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects 1991 ·The Lancet ·Ian Taylor, Kevin M. O’Shaughnessy, Richard W. Fuller, C. T. Dollery	325
12	Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin‐1 1991 ·British Journal of Pharmacology ·(unknown), Richard W. Fuller, James M. Ritter, (unknown), (unknown), C. T. Dollery	6
13	Effect of Inhaled Furosemide and Bumetanide on Adenosine 5′-Monophosphate- and Sodium Metabisulfite-induced Bronchoconstriction in Asthmatic Subjects 1991 ·American Review of Respiratory Disease ·Brian O’Connor, Kian Fan Chung, (unknown), Richard W. Fuller, Peter J. Barnes	75
14	Thromboxane A ₂ Biosynthesis in Acute Asthma and after Antigen Challenge 1991 ·American Review of Respiratory Disease ·Ian Taylor, (unknown), Kevin M. O’Shaughnessy, C. T. Dollery, Peter Black, Susan E. Barrow, Graham W. Taylor, Richard W. Fuller	51
15	The effect of sulindac on the abnormal cough reflex associated with dry cough. 1990 ·Journal of Pharmacology and Experimental Therapeutics ·Jean R. McEwan, Nozhat Choudry, Richard W. Fuller	59
16	Assessment of MK-912, an α2-adrenoceptor antagonist, with use of intravenous clonidine 1989 ·Clinical Pharmacology & Therapeutics ·J. B. Warren, C. T. Dollery, Richard W. Fuller, Vanessa C. Williams, Barry J. Gertz	14
17	Angiotensin Converting Enzyme Inhibitors and Cough 1989 ·Journal of Cardiovascular Pharmacology ·Jean R. McEwan, Richard W. Fuller	30
18	Human alveolar macrophage activation: Inhibition by forskolin but not β-adrenoceptor stimulation or phosphodiesterase inhibition 1988 ·Pulmonary Pharmacology ·Richard W. Fuller, (unknown), Amanda J. Baker, John MacDermot	47
19	[Aneurysm of the pulmonary artery in Behçet's syndrome. Report of a case]. 1986 ·PubMed ·Richard W. Fuller, (unknown), (unknown), (unknown), Moacyr Roberto Cucê Nobre	1
20	Angina pectoris-like pains provoked by intravenous adenosine 1986 ·BMJ ·David Maxwell, Richard W. Fuller, Peter J. Barnes, TB Conradson, CM Dixon	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact